欧州医療大麻市場規模、シェア、トレンド分析レポート
Market Size in USD Billion
CAGR :
% 
USD
3.51 Billion
USD
35.59 Billion
2024
2032
 予測期間 |
2025 –2032 |
 市場規模（基準年） |
USD 3.51 Billion |
 Market Size (Forecast Year) |
USD 35.59 Billion |
 CAGR |
% |
| Major Markets Players |
|
ヨーロッパ医療大麻市場のセグメンテーション、製品別（オイル、乾燥医療大麻、医療大麻カプセル、全花、粉末花、ベイプペン、クリーム＆保湿剤、その他）、原料別（合成および天然）、種別（カンナビスインディカ、サティバ、ハイブリッド）、誘導体別（カンナビジオール（CBD）、テトラヒドロカンナビノール（THC）/デルタ-8-テトラヒドロカンナビノール、その他）、用途別（疼痛管理、不安、筋肉痙攣、吐き気、食欲不振、癌、関節炎、アルツハイマー病/片頭痛、てんかん、うつ病および睡眠障害、多発性硬化症、自閉症、精神疾患、気分高揚、その他）、投与経路別（経口溶液およびカプセル、喫煙、ベイポライザー、局所用、その他）、エンドユーザー別（製薬業界、研究開発センター、在宅ケア施設、病院、リハビリセンターなど）、流通チャネル（B2BおよびB2C） - 2032年までの業界動向と予測
ヨーロッパの医療用大麻市場規模
- ヨーロッパの医療用大麻市場規模は2024年に35億1000万米ドルと評価され、予測期間中に33.60%のCAGRで成長し、2032年には355億9000万米ドル に達すると予想されています 。
- 市場の成長は、主にコネクテッドホームデバイスとスマートホームテクノロジーの採用の増加と技術の進歩によって推進されており、住宅と商業の両方の環境でデジタル化が進んでいます。
- さらに、家庭や事業所向けの安全で使いやすい統合ソリューションに対する消費者の需要の高まりにより、スマートロックは現代のアクセス制御システムとして定着しつつあります。これらの要因が重なり、ヨーロッパにおける医療用大麻ソリューションの普及が加速し、業界の成長を大きく後押ししています。
ヨーロッパの医療用大麻市場分析
- 医療用大麻は、慢性疼痛、てんかん、多発性硬化症、がん関連症状など、さまざまな症状の治療に使用される医薬品グレードの大麻製品を含み、規制枠組みの進化とその治療効果の臨床検証の増加により、ヨーロッパ全土で受け入れられつつあります。
- ヨーロッパにおける医療用大麻の需要は、主に慢性疾患の罹患率の上昇、高齢者人口の増加、政府の支援政策、カンナビノイドベースの治療法への研究投資の増加によって推進されている。
- ドイツは、確立された償還制度、医師による広範な導入、そして強い患者需要に支えられ、2024年にはヨーロッパの医療用大麻市場で最大の収益シェア27.9%を獲得し、市場を席巻しました。規制整備における同国のリーダーシップと、活発な輸入・国内生産エコシステムが、市場の成長を牽引し続けています。
- イタリアは、軍事施設による国内生産、輸入の増加、慢性疼痛および緩和ケア治療の一貫した需要により、予測期間中にヨーロッパの医療大麻市場で最も急速に成長する国となり、2024年には9.7％のCAGRで成長すると予想されています。
- 2024年には、オーガニックおよび植物由来の治療薬への需要の高まりにより、天然由来セグメントがヨーロッパの医療用大麻市場を席巻し、69.3%の市場シェアを獲得しました。天然由来治療薬への患者の嗜好の高まりと、ドイツ、イタリア、オランダなどの主要ヨーロッパ諸国における規制の好意的な姿勢が、その広範な使用を支えています。
レポートの範囲とヨーロッパの医療用大麻市場のセグメンテーション
|
属性 |
ヨーロッパの医療用大麻の主要市場に関する洞察 |
|
対象セグメント |
|
|
対象国 |
ヨーロッパ
|
|
主要な市場プレーヤー |
|
|
市場機会 |
|
|
付加価値データ情報セット |
データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、専門家による詳細な分析、価格設定分析、ブランドシェア分析、消費者調査、人口統計分析、サプライチェーン分析、バリューチェーン分析、原材料/消耗品の概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制の枠組みも含まれています。 |
ヨーロッパの医療用大麻市場の動向
「医療用大麻療法のパーソナライゼーションとデジタル化の進展」
- ヨーロッパの医療用大麻市場において、デジタルヘルスプラットフォームと患者モニタリング技術を通じた個別化治療アプローチの統合は、重要かつ加速的なトレンドとなっています。この進化するモデルは、患者のエンゲージメント、投与量の正確性、医師の監督を強化し、より良い治療成果をもたらします。
- 例えば、ヨーロッパのスタートアップ企業数社は、デジタルヘルスプラットフォームと提携し、AIを活用した大麻の投与量追跡アプリや遠隔医療相談を提供することで、アクセスと個別ケアの向上を図っています。これらのプラットフォームは、患者に滴定スケジュールを指導し、症状を追跡し、リアルタイムのフィードバックに基づいて品種を調整します。
- デジタル統合により、特に痛み、不安、てんかんなどの慢性疾患の管理において、遠隔での患者モニタリングが可能になります。臨床医は治療の進捗、副作用、服薬遵守を遠隔でモニタリングできるため、意思決定が効率化され、患者の安全性が向上します。
- デバイス、アプリ、患者ポータルを横断したシームレスなデジタルエンゲージメントにより、医療大麻が孤立したものではなく、より広範なデジタルケアジャーニーの一部となる、接続された治療エコシステムが構築されます。これにより、医師、薬局、患者間の連携が促進され、より効率的なケア提供が可能になります。
- ヨーロッパのSOMAÍ PharmaceuticalsやCellen Healthなどの企業は、仮想ケアと製品のフルフィルメントおよびデータ分析を融合させた遠隔大麻プラットフォームを積極的に開発し、さまざまなヨーロッパの規制環境にわたって拡張可能でコンプライアンスに準拠した医療大麻治療プログラムを提供しています。
- デジタル統合型で患者中心の大麻療法への需要は、特に若年層やテクノロジーに精通した層、そして慢性疾患患者の間で、地域全体で急速に高まっています。この傾向が勢いを増すにつれ、医療用大麻の提供、サポート、そして有効性のモニタリングに対する期待も変化しつつあります。
ヨーロッパの医療用大麻市場の動向
ドライバ
「慢性疾患の負担増加と治療用大麻の導入によるニーズの高まり」
- がん、てんかん、多発性硬化症、慢性疼痛などの慢性疾患の罹患率の増加と、いくつかのヨーロッパ諸国における医療用大麻の合法化の加速が相まって、医療用大麻製品の需要の高まりの大きな要因となっています。
- 例えば、2024年4月、STENOCARE A/S（デンマーク）は、慢性疼痛および神経疾患の治療成績向上を目的とした新しいオイルベースの医療用大麻製剤を導入し、製品ラインを拡大する計画を発表しました。主要企業によるこのような戦略は、予測期間中の欧州医療用大麻産業の成長を牽引すると予想されます。
- 患者と医療従事者が、従来の医薬品に比べて医療用大麻の臨床的利点と副作用の少なさを認識するにつれ、大麻由来の治療法に対する需要は高まり続けています。これらの製品は、疼痛管理、緩和ケア、メンタルヘルスなどの分野において魅力的な代替手段を提供します。
- さらに、規制改革、パイロットプログラム、輸入承認を通じて欧州政府からの支援が拡大し、医療大麻が患者にとってよりアクセスしやすくなり、主流の医療システムへの統合が加速しています。
- オイル、カプセル、スプレーといった多様な剤形の利便性に加え、電子処方箋サービスや薬局を通じた流通の拡大は、入院患者と外来患者の双方において医療用大麻の導入を促進する重要な要因となっています。植物由来療法へのトレンドと代替医療の普及も、市場の成長に大きく貢献しています。
抑制/挑戦
「規制の複雑さと治療費の高騰に関する懸念」
- 欧州全域における規制環境の断片化と変化は、市場へのより広範な浸透にとって大きな課題となっています。各国の法律、ライセンス制度、輸出入規制の違いにより、メーカーや販売業者が域内で円滑に事業を展開することが困難になっています。
- たとえば、ドイツや英国などの国では医療大麻に関する枠組みが確立されている一方、他の国では依然として政策実施の初期段階にあり、投資家や医療提供者にとって遅延や不確実性が生じています。
- EU全体で統一された法規制、標準化された製品品質ガイドライン、そして透明性の高いライセンス手続きを通じて、これらの規制上の障壁に対処することは、強固で拡張可能な産業を構築するために不可欠です。Aurora CannabisやTilray Brandsなどの企業は、規制当局と積極的に協力し、アクセスの拡大とコンプライアンスの合理化に取り組んでいます。
- さらに、医療用大麻、特に輸入品やGMP認証製品の場合、治療費が比較的高額であることは、無保険患者や費用に敏感な患者にとって、医療大麻の導入を阻む要因となる可能性があります。一部の国では部分的な償還制度を設けていますが、多くの地域では依然としてアクセスが制限されています。
- 現地生産の増加により価格競争力は徐々に高まっているものの、大麻は高級品、あるいは実験的な治療薬であるという認識が、保守的な医療界での広範な導入を妨げ続けています。
- 規制の調整、医師のトレーニング、公衆教育、そしてより手頃な価格で証拠に裏付けられた医療大麻製品の開発を通じてこれらの課題を克服することは、ヨーロッパの医療大麻市場の持続的な成長に不可欠です。
ヨーロッパの医療用大麻市場の展望
市場は、製品、供給源、種、派生物、用途、投与経路、エンドユーザー、流通チャネルに基づいてセグメント化されています。
• 製品別
製品別に見ると、欧州の医療用大麻市場は、オイル、乾燥医療用大麻、医療用大麻カプセル、全花、粉末、ベイプペン、クリーム・保湿剤、その他に分類されます。オイルセグメントは、正確な投与量、投与の容易さ、そして慢性疾患治療における好まれな点から、2024年には34.6%という最大の市場収益シェアを占めました。
医療用大麻カプセル分野は、患者のコンプライアンスの向上と神経疾患および疼痛関連疾患にわたる処方の拡大により、2025年から2032年にかけて22.9%のCAGRで最速の成長率を記録すると予想されています。
• 情報源別
ヨーロッパの医療用大麻市場は、供給源に基づいて合成と天然に分類されます。天然セグメントは、オーガニックおよび植物由来の治療薬への需要増加に牽引され、2024年には69.3%と最大の収益シェアを占めました。
合成セグメントは、研究室で開発されたカンナビノイド製剤の進歩により、2025年から2032年にかけて20.4%という最も高いCAGRを記録すると予想されています。
• 種別
ヨーロッパの医療用大麻市場は、品種に基づいて、インディカ種、サティバ種、ハイブリッド種に分類されます。インディカ種は2024年に41.7%という最大の市場シェアを占め、鎮静作用により鎮痛や不眠症の治療に広く利用されています。
ハイブリッドセグメントは、バランスのとれた治療効果が評価され、2025年から2032年にかけて21.3%という最も高いCAGRを達成すると予想されています。
• デリバティブ取引
欧州の医療用大麻市場は、派生商品に基づいて、カンナビジオール（CBD）、テトラヒドロカンナビノール（THC）/デルタ-8-テトラヒドロカンナビノール、その他に分類されます。カンナビジオール（CBD）セグメントは、その非精神活性性と幅広い治療ポテンシャルにより、2024年には57.8%と最大の収益シェアを占めました。
テトラヒドロカンナビノール（THC）セグメントは、腫瘍学および緩和ケアにおける痛みや吐き気の管理に対する合法化と受容の増加により、2025年から2032年にかけて23.1%という最も高いCAGRで成長すると予測されています。
• アプリケーション別
用途別に見ると、欧州の医療用大麻市場は、疼痛管理、不安、筋痙攣、吐き気、食欲不振、がん、関節炎、アルツハイマー病／片頭痛、てんかん、うつ病および睡眠障害、多発性硬化症、自閉症、精神疾患、気分高揚、その他に分類されます。2024年には、疼痛管理分野が収益シェアの38.5%を占め、次いでがん関連分野が14.2%を占めました。
てんかん分野は、発作抑制におけるカンナビノイドの有効性を裏付ける臨床的証拠の増加により、2025年から2032年にかけて22.6%という最も高いCAGRを記録すると予想されています。
• 投与経路
投与経路に基づいて、欧州の医療用大麻市場は、経口溶液およびカプセル、喫煙、気化器、局所用、その他に分類されます。経口溶液およびカプセルセグメントは、使いやすさと投与量の正確さに牽引され、2024年には36.8%という最大の市場シェアを獲得しました。
気化器セグメントは、その効果の発現が早く、若い世代の間で使用が増えていることから、2025年から2032年にかけて21.5%という最も高いCAGRを記録すると予測されています。
• エンドユーザーによる
欧州の医療用大麻市場は、エンドユーザーに基づいて、製薬業界、研究開発センター、在宅ケア施設、病院、リハビリセンター、その他に分類されます。製薬業界セグメントは、臨床試験と医薬品開発の増加に支えられ、2024年には32.4%という最大の収益シェアを獲得しました。
在宅ケア設定セグメントは、患者中心の在宅大麻治療の需要の高まりにより、2025年から2032年にかけて22.7％という最も高いCAGRで成長すると予想されています。
• 流通チャネル別
流通チャネルに基づいて、市場はB2BとB2Cに区分されます。B2Bセグメントは、薬局や病院による大量調達の牽引により、2024年には60.1%と最大の収益シェアを占めました。
B2Cセグメントは、欧州全域での電子薬局と消費者直販プラットフォームの増加により、2025年から2032年にかけて24.2%という最も高いCAGRで成長すると予想されています。
ヨーロッパ医療大麻市場の地域分析
- ドイツは、確立された規制枠組み、医師による広範な導入、そして保険適用の処方箋によって、2024年にはヨーロッパの医療用大麻市場で最大の収益シェア27.9%を獲得し、市場を席巻しました。同国の強力な輸入能力と国内生産の拡大は、患者のアクセスをさらに向上させ、長期的な市場リーダーシップを維持しています。
- ヨーロッパの主要国の消費者は、慢性的な痛み、神経疾患、がん関連の症状、メンタルヘルスのサポートのために医療用大麻にますます目を向けており、安全性、有効性、処方箋に基づいたアクセスのために、オイル、乾燥花、カプセルなどの規制された製品を好んでいます。
- 大麻由来治療への意識の高まり、慢性疾患の有病率の増加、そして大麻法の進歩的な改革により、大陸全体で需要が加速しています。英国、フランス、イタリアなどの国では、大麻アクセスプログラムや臨床試験への患者登録が増加しています。
英国・欧州の医療用大麻市場の洞察
英国・欧州の医療用大麻市場は、2024年に欧州医療用大麻市場における収益シェアの18.6%を獲得しました。これは、民間の大麻クリニックの増加、認知度の高まり、そして国民保健サービス（NHS）以外での治療を求める患者の意欲に支えられています。デジタル処方プラットフォームの拡大と規制の明確化により、力強い成長が期待されています。
フランス・ヨーロッパの医療用大麻市場の洞察
フランスの欧州医療大麻市場は、国家レベルの医療大麻パイロットプログラムと政府支援の拡大に支えられ、2024年には欧州医療大麻市場の11.3%を占めました。試験段階後の本格的な市場参入により、予測期間中の成長が大幅に加速すると予想されます。
イタリア・ヨーロッパの医療用大麻市場の洞察
イタリア・ヨーロッパの医療用大麻市場は、軍事施設を通じた国内生産、輸入の増加、そして慢性疼痛および緩和ケア治療に対する堅調な需要に牽引され、2024年には9.7%という最高の年平均成長率（CAGR）を達成すると予想されています。同国の成熟した規制体制は、市場の継続的な安定を支えています。
ヨーロッパの医療用大麻市場シェア
ヨーロッパの医療用大麻産業は、主に以下のような老舗企業によって牽引されています。
- オーロラ・カンナビス社（カナダ）
- キャノピー・グロース・コーポレーション（カナダ）
- ティルレイ・ブランズ社（カナダ）
- ジャズ・ファーマシューティカルズ社（アイルランド）
- STENOCARE A/S（デンマーク）
- デメカンGmbH（ドイツ）
- ウェイランドグループ社（ドイツ）
- Cannamedical Pharma GmbH（ドイツ）
- Bedrocan International BV（オランダ）
- パナクシア製薬工業株式会社（イスラエル）
- IMカンナビス・コーポレーション（イスラエル）
- リトルグリーンファーマ株式会社（オーストラリア）
- PharmaCielo Ltd.（カナダ）
- キロンライフサイエンス社（コロンビア）
- アルテア・グループ・ホールディングス（オーストラリア）
欧州医療大麻市場の最新動向
- 2024年5月、ドイツで大麻法が施行され、大麻は麻薬から医薬品へと再分類されました。この規制変更により、遠隔医療相談、処方箋の簡素化、そして個人栽培と所持の合法化が実現し、市場の急速な成長が促進されました。ドイツの患者数は2024年4月の25万人から2025年5月には90万人近くに急増し、市場規模は年間で10億ユーロ（約11億米ドル）を超えると予測されています。
- 2025年1月、オーロラ・カンナビスは、インディメッドブランドで初のドイツ産医療用大麻の発売を発表し、欧州市場における垂直統合と現地供給戦略の拡大を示唆した。
- 2024年6月、グラスファームズは英国を拠点とする最初の生産者となり、MHRA認可の地元産大麻花を郵送で配送し、ヨーロッパの国内生産と流通能力の画期的な出来事となりました。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of Europe MEDICAL CANNABIS market
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- PRODUCT LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- market application coverage grid
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insights
- EUROPE MEDICAL CANNABIS MARKET: REGULATIONS
- UNITED STATES
- CANADA
- AUSTRALIA
- THAILAND
- EUROPE MEDICAL CANNABIS MARKET: SUPPLY CHAIN ANALYSIS
- CULTIVATORS AND GROWERS
- MANUFACTURER AND PRODUCER
- TESTERS
- WHOLESALE AND DISTRIBUTORS
- RETAILERS
- Market Overview
- DRIVERS
- INCREASED MEDICINAL USE
- LEGALIZATION OF CANNABIS
- INITIATIVES TAKEN BY MANUFACTURERS
- INCREASED USAGE OF CANNABIS SEEDS IN COSMETIC PRODUCTS
- FUNCTIONAL PROPERTIES OF CANNABIS AND THEIR INCREASED USE IN DIFFERENT INDUSTRIES
- RESTRAINTS
- COMPLEX REGULATORY STRUCTURE FOR USAGE OF CANNABIS
- LONG TERM USE CAN CAUSE ADVERSE EFFECTS
- HIGH COST
- OPPORTUNITIES
- NOVEL PRODUCT DEVELOPMENT WITH INCREASING R & D ACTIVITIES
- INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSE
- GROWING GERIATRIC POPULATION
- INCREASING PREVALENCE OF CHRONIC DISEASES
- CHALLENGES
- RISE OF MARIJUANA BLACK MARKET
- SIDE EFFECTS RELATED TO THE USE OF CANNABIS
- SHORTAGE OF PERSONNEL
- IMPACT OF COVID-19 ON EUROPE MEDICAL CANNABIS MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY
- KEY INITIATIVES BY MARKET PLAYER DURING COVID 19
- CONCLUSION:
- EUROPE MEDICAL CANNABIS MARKET, BY product
- overview
- oil
- By Type
- CBD Oil Concentrates
- CBD Vape Oil
- CBD Tinctures
- By Source
- Marijuana Based
- Hemp Based
- By Species
- Sativa
- Hybrid
- Cannabis Indica
- Dried Medical cannabis
- Cannabis Indica
- Sativa
- Hybrid
- medical cannabis capsules
- By Type
- Oil Based Cannabis Capsules
- Power Based Cannabis Capsules
- Others
- By Concentrates
- High CBD Capsules Digital
- High THC Capsule
- THC/CBD balanced capsule
- CBD Isolate Capsule
- By Species
- Sativa
- Hybrid
- Cannabis Indica
- vape pen
- Cannabis Indica
- Sativa
- Hybrid
- whole flower
- Sativa
- Hybrid
- Cannabis Indica
- CREAMS & MOISTURIZER
- Ground Flower
- Sativa
- Cannabis Indica
- Hybrid
- patch
- mask & serum
- cleanser
- others
- EUROPE MEDICAL CANNABIS MARKET, BY application
- overview
- pain management
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Ground Flower
- Creams & Moisturizer
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- anxiety
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- muscle spasms
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Creams & Moisturizer
- Ground Flower
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- nausea
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Ground Flower
- Creams & Moisturizer
- Patch
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- appetite loss
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Ground Flower
- Whole Flower
- Vape Pen
- Patch
- Others
- cancer
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- arthritis
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Ground Flower
- Creams & Moisturizer
- Masks & Serum
- Whole Flower
- Vape Pen
- Cleanser
- Others
- alzheimer’s disease/Migranes
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- epilepsy
- Oil
- Medical cannabis and capsules
- Others
- depression and sleep disorders
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Creams & Moisturizer
- Others
- multiple sclerosis
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- autism
- Oil
- Medical cannabis and capsules
- Others
- mental health conditions
- Oil
- Medical cannabis and capsules
- Others
- elevate Mood
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Creams & Moisturizer
- Masks & Serum
- Cleanser
- Others
- others
- EUROPE MEDICAL CANNABIS MARKET, BY derivatives
- overview
- CANNABIDIOL (CBD)
- Oil
- Medical Cannabis Capsules
- Ground Flower
- Patch
- Creams & Moisturizer
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- tetrahydrocannabinol (thc)/Delta-8-TETRAHYDROCANNABINOL
- Oil
- Medical Cannabis Capsules
- Dried Medical Cannabis
- Ground Flower
- Patch
- Creams & Moisturizer
- Whole Flower
- Vape Pen
- Masks & Serum
- Cleanser
- Others
- CANNABIGEROL (CBG)
- Oil
- Whole Flower
- Medical cannabis and capsules
- Cleanser
- cannabinol (CBN)
- others
- EUROPE MEDICAL CANNABIS MARKET, BY source
- overview
- natural
- synthetic
- EUROPE MEDICAL CANNABIS MARKET, BY species
- overview
- sativa
- hybrid
- cannabis indica
- EUROPE MEDICAL CANNABIS MARKET, BY route of administration
- overview
- oral solutions and capsules
- smoking
- topicals
- vaporizers
- others
- EUROPE MEDICAL CANNABIS MARKET, BY end user
- overview
- homecare setting
- hospital
- rehab centers
- PHARMACEUTICAL INDUSTRY
- research and development centers
- others
- EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL
- overview
- B2C
- Pharmacies
- Conventional Stores
- Online Stores
- Others
- B2B
- Europe medical cannabis MARKET by geography
- europe
- germany
- italy
- u.k.
- NETHERLANDS
- switzerland
- france
- russia
- spain
- belgium
- rest of europe
- Europe Medical Cannabis market: COMPANY landscape
- company share analysis: Europe
- Swot analysis
- company profile
- MEDIPHARM LABS INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- APHRIA INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- tilray
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Zenabis Europe Ltd.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AURORA CANNABIS
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- gw pharmaceuticals plc
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Althea Company Pty Ltd (A subsidiary of Althea Group)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Apothecanna
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- bARNEY’S FARM
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Bioactive solutions, inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- bol pharma
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- CANNABIS SEEDS USA
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- canopy growth corporation
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Cresco Labs
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Crop King Seeds
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- discover health llc
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- EcoGen Biosciences
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Elixinol Europe limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- endoca
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- EXTRACTAS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- FOLIUM BIOSCIENCES
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- GREENWICH BIOSCIENCES, INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HARMONY
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HUMBOLDT SEED COMPANY
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- IDT AUSTRALIA
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- kiehl’s (a subsidiary of L'Oréal)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- mary’s nutritionals, LLC
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- medical marijuana, inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- MEDIFARM
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- pacific roots
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- pharmahemp
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- pure ratios
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- PEACE NATURALS PROJECT INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- seed Cellar
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- SEEDS FOR ME
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- THC EUROPE GROUP LIMITED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- upstate elevator supply co.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- vermont hemp health
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
表のリスト
TABLE 1 Annual Cost of Cultivation:
TABLE 2 Annual Cost of Manufacturing:
TABLE 3 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED
TABLE 26 Europe MEDICAL CANNABIS market, By application, 2019-2028 (USD million)
TABLE 27 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 28 Europe Pain Management in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 29 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS market, by anxiety, By Region, 2021-2028 (USD Million)
TABLE 30 Europe Pain Management in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 31 EUROPE muscle spasms IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 32 Europe muscle spasms in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 33 EUROPE nausea IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 34 Europe nausea in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 35 EUROPE appetite loss IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 36 Europe appetite loss in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 37 EUROPE cancer IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 38 Europe cancer in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 39 EUROPE arthritis IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 40 Europe arthritis in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 41 EUROPE ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 42 Europe ALZHEIMER’S DISEASE/MIGRANES in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 43 EUROPE epilepsy IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 44 Europe epilepsy in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 45 EUROPE depression and sleep disorders IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 46 Europe depression and sleep disorders in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 47 EUROPE multiple sclerosis IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 48 Europe multiple sclerosis in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 49 EUROPE autism IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 50 Europe autism in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 51 EUROPE mental health conditions IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 52 Europe mental health conditions in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 53 EUROPE elevate mood IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 54 Europe elevate mood in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 55 EUROPE others IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 65 Europe medical cannabis Market, BY source, 2019-2028 (USD MILLION)
TABLE 66 Europe natural in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 67 Europe synthetic in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 68 Europe medical cannabis Market, By Species, 2019-2028 (USD Million)
TABLE 69 Europe sativa in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 70 Europe hybrid in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 71 Europe cannabis indica in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 72 Europe medical cannabis Market, By route of administration, 2019-2028 (USD Million)
TABLE 73 Europe oral solutions and capsules in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 74 Europe smoking in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 75 Europe topicals in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 76 Europe vaporizers in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 77 Europe others in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 78 Europe medical cannabis Market, BY end user, 2019-2028 (USD MILLION)
TABLE 79 Europe homecare setting in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 80 Europe hospital in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 81 Europe rehab centers in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 82 Europe pharmaceutical industry in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 83 Europe research and development centers in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 84 Europe others in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 85 Europe medical cannabis Market, By DISTRIBUTION CHANNEL, 2019-2028 (USD Million)
TABLE 86 Europe b2c in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 87 Europe b2C in medical cannabis Market, By distribution channel, 2019-2028 (USD Million)
TABLE 88 Europe b2b in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 89 europe medical cannabis Market, By COUNTRY, 2021-2028 (USD million)
TABLE 90 EUROPE medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 91 EUROPE type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 92 EUROPE source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 93 EUROPE species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 94 EUROPE dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 95 EUROPE type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 96 EUROPE concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 97 EUROPE species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 98 EUROPE vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 99 EUROPE whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 100 EUROPE ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 101 EUROPE medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 102 EUROPE medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 103 EUROPE medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 104 EUROPE cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 105 EUROPE tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 106 EUROPE cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 107 EUROPE medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 108 EUROPE pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 109 EUROPE anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 110 EUROPE muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 111 EUROPE nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 112 EUROPE appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 113 EUROPE cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 114 EUROPE arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 115 EUROPE alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 116 EUROPE epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 117 EUROPE depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 118 EUROPE multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 119 EUROPE autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 120 EUROPE mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 121 EUROPE elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 122 EUROPE medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 123 EUROPE medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 124 EUROPE medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 125 EUROPE B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 126 GERMANY medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 127 GERMANY type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 128 GERMANY source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 129 GERMANY species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 130 GERMANY dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 131 GERMANY type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 132 GERMANY concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 133 GERMANY species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 134 GERMANY vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 135 GERMANY whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 136 GERMANY ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 137 GERMANY medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 138 GERMANY medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 139 GERMANY medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 140 GERMANY cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 141 GERMANY tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 142 GERMANY cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 143 GERMANY medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 144 GERMANY pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 145 GERMANY anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 146 GERMANY muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 147 GERMANY nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 148 GERMANY appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 149 GERMANY cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 150 GERMANY arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 151 GERMANY alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 152 GERMANY epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 153 GERMANY depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 154 GERMANY multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 155 GERMANY autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 156 GERMANY mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 157 GERMANY elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 158 GERMANY medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 159 GERMANY medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 160 GERMANY medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 161 GERMANY B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 162 ITALY medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 163 ITALY type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 164 ITALY source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 165 ITALY species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 166 ITALY dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 167 ITALY type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 168 ITALY concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 169 ITALY species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 170 ITALY vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 171 ITALY whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 172 ITALY ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 173 ITALY medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 174 ITALY medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 175 ITALY medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 176 ITALY cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 177 ITALY tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 178 ITALY cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 179 ITALY medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 180 ITALY pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 181 ITALY anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 182 ITALY muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 183 ITALY nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 184 ITALY appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 185 ITALY cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 186 ITALY arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 187 ITALY alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 188 ITALY epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 189 ITALY depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 190 ITALY multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 191 ITALY autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 192 ITALY mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 193 ITALY elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 194 ITALY medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 195 ITALY medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 196 ITALY medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 197 ITALY B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 198 U.K. medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 199 U.K. type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 200 U.K. source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 201 U.K. species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 202 U.K. dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 203 U.K. type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 204 U.K. concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 205 U.K. species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 206 U.K. vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 207 U.K. whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 208 U.K. ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 209 U.K. medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 210 U.K. medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 211 U.K. medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 212 U.K. cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 213 U.K. tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 214 U.K. cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 215 U.K. medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 216 U.K. pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 217 U.K. anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 218 U.K. muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 219 U.K. nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 220 U.K. appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 221 U.K. cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 222 U.K. arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 223 U.K. alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 224 U.K. epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 225 U.K. depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 226 U.K. multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 227 U.K. autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 228 U.K. mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 229 U.K. elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 230 U.K. medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 231 U.K. medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 232 U.K. medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 233 U.K. B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 234 NETHERLANDS medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 235 NETHERLANDS type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 236 NETHERLANDS source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 237 NETHERLANDS species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 238 NETHERLANDS dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 239 NETHERLANDS type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 240 NETHERLANDS concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 241 NETHERLANDS species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 242 NETHERLANDS vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 243 NETHERLANDS whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 244 NETHERLANDS ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 245 NETHERLANDS medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 246 NETHERLANDS medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 247 NETHERLANDS medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 248 NETHERLANDS cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 249 NETHERLANDS tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 250 NETHERLANDS cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 251 NETHERLANDS medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 252 NETHERLANDS pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 253 NETHERLANDS anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 254 NETHERLANDS muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 255 NETHERLANDS nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 256 NETHERLANDS appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 257 NETHERLANDS cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 258 NETHERLANDS arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 259 NETHERLANDS alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 260 NETHERLANDS epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 261 NETHERLANDS depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 262 NETHERLANDS multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 263 NETHERLANDS autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 264 NETHERLANDS mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 265 NETHERLANDS elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 266 NETHERLANDS medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 267 NETHERLANDS medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 268 NETHERLANDS medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 269 NETHERLANDS B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 270 SWITZERLAND medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 271 SWITZERLAND type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 272 SWITZERLAND source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 273 SWITZERLAND species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 274 SWITZERLAND dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 275 SWITZERLAND type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 276 SWITZERLAND concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 277 SWITZERLAND species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 278 SWITZERLAND vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 279 SWITZERLAND whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 280 SWITZERLAND ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 281 SWITZERLAND medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 282 SWITZERLAND medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 283 SWITZERLAND medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 284 SWITZERLAND cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 285 SWITZERLAND tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 286 SWITZERLAND cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 287 SWITZERLAND medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 288 SWITZERLAND pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 289 SWITZERLAND anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 290 SWITZERLAND muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 291 SWITZERLAND nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 292 SWITZERLAND appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 293 SWITZERLAND cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 294 SWITZERLAND arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 295 SWITZERLAND alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 296 SWITZERLAND epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 297 SWITZERLAND depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 298 SWITZERLAND multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 299 SWITZERLAND autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 300 SWITZERLAND mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 301 SWITZERLAND elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 302 SWITZERLAND medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 303 SWITZERLAND medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 304 SWITZERLAND medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 305 SWITZERLAND B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 306 FRANCE medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 307 FRANCE type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 308 FRANCE source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 309 FRANCE species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 310 FRANCE dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 311 FRANCE type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 312 FRANCE concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 313 FRANCE species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 314 FRANCE vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 315 FRANCE whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 316 FRANCE ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 317 FRANCE medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 318 FRANCE medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 319 FRANCE medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 320 FRANCE cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 321 FRANCE tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 322 FRANCE cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 323 FRANCE medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 324 FRANCE pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 325 FRANCE anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 326 FRANCE muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 327 FRANCE nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 328 FRANCE appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 329 FRANCE cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 330 FRANCE arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 331 FRANCE alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 332 FRANCE epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 333 FRANCE depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 334 FRANCE multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 335 FRANCE autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 336 FRANCE mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 337 FRANCE elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 338 FRANCE medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 339 FRANCE medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 340 FRANCE medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 341 FRANCE B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 342 RUSSIA medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 343 RUSSIA type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 344 RUSSIA source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 345 RUSSIA species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 346 RUSSIA dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 347 RUSSIA type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 348 RUSSIA concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 349 RUSSIA species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 350 RUSSIA vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 351 RUSSIA whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 352 RUSSIA ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 353 RUSSIA medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 354 RUSSIA medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 355 RUSSIA medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 356 RUSSIA cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 357 RUSSIA tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 358 RUSSIA cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 359 RUSSIA medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 360 RUSSIA pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 361 RUSSIA anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 362 RUSSIA muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 363 RUSSIA nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 364 RUSSIA appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 365 RUSSIA cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 366 RUSSIA arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 367 RUSSIA alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 368 RUSSIA epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 369 RUSSIA depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 370 RUSSIA multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 371 RUSSIA autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 372 RUSSIA mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 373 RUSSIA elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 374 RUSSIA medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 375 RUSSIA medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 376 RUSSIA medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 377 RUSSIA B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 378 SPAIN medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 379 SPAIN type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 380 SPAIN source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 381 SPAIN species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 382 SPAIN dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 383 SPAIN type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 384 SPAIN concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 385 SPAIN species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 386 SPAIN vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 387 SPAIN whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 388 SPAIN ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 389 SPAIN medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 390 SPAIN medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 391 SPAIN medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 392 SPAIN cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 393 SPAIN tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 394 SPAIN cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 395 SPAIN medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 396 SPAIN pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 397 SPAIN anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 398 SPAIN muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 399 SPAIN nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 400 SPAIN appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 401 SPAIN cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 402 SPAIN arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 403 SPAIN alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 404 SPAIN epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 405 SPAIN depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 406 SPAIN multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 407 SPAIN autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 408 SPAIN mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 409 SPAIN elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 410 SPAIN medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 411 SPAIN medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 412 SPAIN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 413 SPAIN B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 414 BELGIUM medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 415 BELGIUM type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 416 BELGIUM source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 417 BELGIUM species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 418 BELGIUM dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 419 BELGIUM type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 420 BELGIUM concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 421 BELGIUM species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 422 BELGIUM vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 423 BELGIUM whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 424 BELGIUM ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 425 BELGIUM medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 426 BELGIUM medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 427 BELGIUM medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 428 BELGIUM cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 429 BELGIUM tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 430 BELGIUM cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 431 BELGIUM medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 432 BELGIUM pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 433 BELGIUM anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 434 BELGIUM muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 435 BELGIUM nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 436 BELGIUM appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 437 BELGIUM cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 438 BELGIUM arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 439 BELGIUM alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 440 BELGIUM epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 441 BELGIUM depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 442 BELGIUM multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 443 BELGIUM autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 444 BELGIUM mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 445 BELGIUM elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 446 BELGIUM medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 447 BELGIUM medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 448 BELGIUM medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 449 BELGIUM B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 450 rest of europe medical cannabis Market, By product, 2021-2028 (USD million)
図表一覧
FIGURE 1 Europe medical cannabis market: segmentation
FIGURE 2 Europe medical cannabis market: data triangulation
FIGURE 3 Europe medical cannabis market: DROC ANALYSIS
FIGURE 4 Europe medical cannabis market : Europe vs REGIONAL MARKET ANALYSIS
FIGURE 5 Europe medical cannabis market : COMPANY RESEARCH ANALYSIS
FIGURE 6 Europe medical cannabis market: INTERVIEW DEMOGRAPHICS
FIGURE 7 Europe medical cannabis market: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE medical cannabis MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 Europe medical cannabis market: vendor share analysis
FIGURE 10 Europe medical cannabis market: SEGMENTATION
FIGURE 11 increasing medicinal use and legalization of medical cannabis are expected to drive THE Europe medical cannabis market IN THE FORECAST PERIOD of 2021 to 2028
FIGURE 12 oil segment is expected to account for the largest share of the Europe medical cananbis market in 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE MEDICAL CANNABIS MARKET
FIGURE 14 Europe MEDICAL CANNABIS market: BY product, 2020
FIGURE 15 Europe MEDICAL CANNABIS market: BY product, 2021-2028 (USD Million)
FIGURE 16 Europe MEDICAL CANNABIS market: BY product, CAGR (2021-2028)
FIGURE 17 Europe MEDICAL CANNABIS market: BY product, LIFELINE CURVE
FIGURE 18 Europe MEDICAL CANNABIS market: BY application, 2020
FIGURE 19 Europe MEDICAL CANNABIS market: BY application, 2021-2028 (USD Million)
FIGURE 20 Europe MEDICAL CANNABIS market: BY application, CAGR (2021-2028)
FIGURE 21 Europe MEDICAL CANNABIS market: BY application, LIFELINE CURVE
FIGURE 22 Europe MEDICAL CANNABIS market: BY DERIVATIVES, 2020
FIGURE 23 Europe MEDICAL CANNABIS market: BY DERIVATIVES, 2021-2028 (USD Million)
FIGURE 24 Europe MEDICAL CANNABIS market: BY DERIVATIVES, CAGR (2021-2028)
FIGURE 25 Europe MEDICAL CANNABIS market: BY DERIVATIVES, LIFELINE CURVE
FIGURE 26 Europe MEDICAL CANNABIS market: BY source, 2020
FIGURE 27 Europe MEDICAL CANNABIS market: BY source, 2021-2028 (USD Million)
FIGURE 28 Europe MEDICAL CANNABIS market: BY source, CAGR (2021-2028)
FIGURE 29 Europe MEDICAL CANNABIS market: BY source, LIFELINE CURVE
FIGURE 30 Europe MEDICAL CANNABIS market: BY species, 2020
FIGURE 31 Europe MEDICAL CANNABIS market: BY species, 2021-2028 (USD Million)
FIGURE 32 Europe MEDICAL CANNABIS market: BY species, CAGR (2021-2028)
FIGURE 33 Europe MEDICAL CANNABIS market: BY species, LIFELINE CURVE
FIGURE 34 Europe MEDICAL CANNABIS market: BY route of administration, 2020
FIGURE 35 Europe MEDICAL CANNABIS market: BY route of administration, 2021-2028 (USD Million)
FIGURE 36 Europe MEDICAL CANNABIS market: BY route of administration, CAGR (2021-2028)
FIGURE 37 Europe MEDICAL CANNABIS market: BY route of administration, LIFELINE CURVE
FIGURE 38 Europe MEDICAL CANNABIS market: BY end user, 2020
FIGURE 39 Europe MEDICAL CANNABIS market: BY end user, 2021-2028 (USD Million)
FIGURE 40 Europe MEDICAL CANNABIS market: BY end user, CAGR (2021-2028)
FIGURE 41 Europe MEDICAL CANNABIS market: BY end user, LIFELINE CURVE
FIGURE 42 Europe MEDICAL CANNABIS market: BY distribution channel, 2020
FIGURE 43 Europe MEDICAL CANNABIS market: BY distribution channel , 2021-2028 (USD Million)
FIGURE 44 Europe MEDICAL CANNABIS market: BY distribution channel , CAGR (2021-2028)
FIGURE 45 Europe MEDICAL CANNABIS market: BY distribution channel, LIFELINE CURVE
FIGURE 46 europe medical cannabis MARKET: SNAPSHOT (2020)
FIGURE 47 europe medical cannabis MARKET: BY COUNTRY (2020)
FIGURE 48 europe medical cannabis MARKET: BY COUNTRY (2021 & 2028)
FIGURE 49 europe medical cannabis MARKET: BY COUNTRY (2020 & 2028)
FIGURE 50 europe medical cannabis MARKET: BY type (2021-2028)
FIGURE 51 Europe Medical Cannabis market: company share 2020 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
